Argyle Capital Management’s GENEREX BIOTECHNOLOGY CORP GNBT Stock Holding History

Argyle Capital Management’s Portfolio GNBT Stock Details GNBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-10,000	Closed	–	–	111
2013 Q4	$0	Hold	10,000	–	–	﹤0.01%	112
2013 Q3	$0	Hold	10,000	–	–	﹤0.01%	110
2013 Q2	$0	Buy	+10,000	New	–	﹤0.01%	108

Other funds holding GNBT

Janney Montgomery Scott Philadelphia, Pennsylvania $40.4B AUM 21.2% 1-Year Est. Return

Argyle Capital Management's GNBT Position: Q1 2014 in Review

Argyle Capital Management sold out of GENEREX BIOTECHNOLOGY CORP (GNBT) in Q1 2014, closing a stake of 10,000 shares.

Argyle Capital Management first reported a position in GNBT in Q2 2013 and held it in 3 quarters. The position peaked at $0 in Q4 2013. 2 funds tracked by Wall St. Rank hold GNBT as of Q1 2014.

Argyle Capital Management reported no remaining GENEREX BIOTECHNOLOGY CORP position as of Q1 2014 after selling out during the quarter.
Argyle Capital Management sold 10,000 GENEREX BIOTECHNOLOGY CORP shares in Q1 2014.
Argyle Capital Management first reported a position in GENEREX BIOTECHNOLOGY CORP in Q2 2013 and held it in 3 quarters.
Argyle Capital Management's GENEREX BIOTECHNOLOGY CORP position peaked at $0 in Q4 2013.
2 funds tracked by Wall St. Rank held GENEREX BIOTECHNOLOGY CORP as of Q1 2014.

Based on Argyle Capital Management's 13F filing for Q1 2014, filed 24 Apr 2014.